p53 Expression in pituitary adenomas and carcinomas: Correlation with invasiveness and tumor growth fractions

Neurosurgery

Volumn 38, Issue 4, 1996, Pages 765-771

  Thapar, Kamal ^a   Scheithauer, Bernd W ^b   Kovacs, Kalman ^a   Pernicone, Peter J ^c   Laws Jr , Edward R ^d  

^a ST MICHAEL'S HOSPITAL   (Canada)

^b MAYO CLINIC   (United States)

^c FLORIDA HOSPITAL   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

Immunohistochemistry; p53; Pituitary adenomas; Pituitary carcinomas; Proliferation markers

Indexed keywords

PROTEIN P53; KI 67 ANTIGEN; NUCLEAR PROTEIN; TUMOR MARKER; TUMOR PROTEIN;

ADULT; ARTICLE; CANCER INVASION; CARCINOMA; CELL DIFFERENTIATION; CONTROLLED STUDY; ELECTRON MICROSCOPY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; TUMOR GROWTH; ADENOMA; CELL DIVISION; CELL NUCLEUS; ENZYME IMMUNOASSAY; HYPOPHYSIS; HYPOPHYSIS TUMOR; MIDDLE AGED; PATHOLOGY; PHYSIOLOGY;

ADENOMA; ADULT; CARCINOMA; CELL DIVISION; CELL NUCLEUS; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KI-67 ANTIGEN; MALE; MICROSCOPY, ELECTRON; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM PROTEINS; NUCLEAR PROTEINS; PITUITARY GLAND; PITUITARY NEOPLASMS; PROGNOSIS; TUMOR MARKERS, BIOLOGICAL; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0029917618     PISSN: 0148396X     EISSN: None     Source Type: Journal    
DOI: 10.1227/00006123-199604000-00027     Document Type: Article

References (38)

1. Battifora H: p53 immunohistochemistry: A word of caution. Hum Pathol 25:435-436, 1994.
2. Bourhis T, Bosq J, Wilson GD, Bressac B, Talbot M, Leridant AM, Dendale R, Janin N, Armand JP, Luboinski B, Malaise EP, Wibault P, Eschwege F: Correlation between p53 gene expression and tumor-cell proliferation in oropharyngeal cancer. Int J Cancer 57:458-462, 1994.
3. Buckley N, Bates AS, Broome J, Strange R, Perrett C, Burke C, Clayton R: p53 protein accumulates in Cushing's adenomas and invasive non-functional adenomas. J Clin Endocrinol Metab 79: 1513-1516, 1994.
4. Carbone DP, Mitsudomi T, Chiba I, Piantadoci S, Rusch V, Nowak JA, McIntire D, Slimon D, Gazdar A, Minna J: p53 immunostaining is associated with reduced survival and is imperfectly correlated with gene mutations in resected non-small cell lung cancer: A preliminary report of the LCSG 871. Chest 106[Suppl 6]:377S-381S, 1994.
5. Cohen C, DeRose P: Immunohistochemical p53 in hepatocellular carcinoma and liver cell dysplasia. Mod Pathol 7:536-539, 1994.
6. Esrig D, Elmajian D, Groshen S, Freeman JA, Stein JP, Chen S-C, Nichols PW, Skinner DG, Jones PA, Cote RJ: Accumulation of nuclear p53 and tumor progression in bladder cancer. N Engl J Med 331:1259-1264, 1994.
7. Gelsleichter L, Gown A, Zarbo R, Wang E, Coltrera M: p53 and mdm-2 expression in malignant melanoma: An immunocytochemical study of expression of p53, mdm-2 and markers of cell proliferation in primary versus metastatic tumors. Mod Pathol 8:530-535, 1995.
8. Harris C, Hollstein M: Clinical implications of the p53 tumor-suppressor gene. N Engl J Med 329:1318-1327, 1993.
9. Herman V, Drazin NZ, Gonsky R, Melmed S: Molecular screening of pituitary adenomas for gene mutations and rearrangements. J Clin Endocrinol Metab 77:50-55, 1993.
10. Hollstein M, Sidransky D, Vogelstein B, Harris C: p53 mutations in human cancer. Science 253:49-53, 1991.
11. Hsu SM, Raine L, Fanger H: The use of antiavidin antibody and avidin-biorin peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 75:816-821, 1981.
12. Jensen RA, Page DL: p53: The promising story continues to unfold. Hum Pathol 24:455-456, 1993.
13. Kaklamanis L, Gatter K, Mortensen N, Baigrie R, Heryet A, Lane D, Harris A: p53 expression in colorectal adenomas. Am J Pathol 142:87-93, 1993.
14. Kennedy SM, MacGeogh C, Jaffe R, Spurr NK: Overexpression of the oncoprotein p53 in primary hepatic tumors of childhood does not correlate with gene mutations. Hum Pathol 25:438-442, 1994.
15. Kohler M, Berchuck A, Davidoff AM, Humphrey PA, Dodge RK, Inglehart JD, Soper JT, Clarke-Pearson DL, Bast RC, Marks JR: Overexpression and mutation of p53 in endometrial carcinoma. Cancer Res 52:1622-1627, 1992.
16. Kovacs K, Horvath E: Tumors of the Pituitary Gland: Atlas of Tumor Pathology. Washington, D.C., Armed Forces Institute of Pathology, 1986, series 2, pp 1-269.
17. Levine AJ, Chang A, Dittmer D, Notterman DA, Silver A, Thorn K, Welsh D, Wu M: The p53 tumor suppressor gene. J Lab Clin Med 123:817-823, 1994.
18. Levine AJ, Momand J, Finlay CA: The p53 tumor suppressor gene. Nature 351:453-456, 1991.
19. Levine AJ, Perry ME, Chang A, Silver D, Dittmer D, Wu M, Welsh D: The 1993 Walter Hubert Lecture: The role of the p53 tumour-suppressor gene in tumorigenesis. Br J Cancer 69:409-416, 1994.
20. Levy A, Hall L, Yeudall WA, Lightman SL: p53 gene mutations in pituitary adenomas: Rare events. Clin Endocrinol (Oxf) 41:809-814, 1994.
21. Martin H, Filipe M, Morris RW, Lane DP, Silvestre F: p53 expression and prognosis in gastric carcinoma. Int J Cancer 50:859-862, 1992.
22. Nagao T, Kondo F, Sato T, Nagato Y, Kondo Y: Immunohistochemical detection of aberrant p53 expression in hepatocellular carcinoma: Correlation with cell proliferative activity indices, including mitotic index and MIB-1 immunostaining. Hum Pathol 26:326-333, 1995.
23. Niemann T, Raab S, Lenel J, Rodgers J, Robinson R: p53 protein over-expression in smooth muscle tumors of the uterus. Hum Pathol 26:375-379, 1995.
24. Oyasu R, Nan L, Szumel RC, Kawamata H, Hirohashi S: p53 gene mutations in human urothelial carcinomas: Analysis by immunohistochemistry and single-strand conformation polymorphism. Mod Pathol 8:170-176, 1995.
25. Pei L, Melmed S, Scheithauer BW, Kovacs K, Prager D: H-ras mutations in human pituitary carcinoma metastases. J Clin Endocrinol Metab 78:842-846, 1994.
26. Pernicone PJ, Scheithauer BW: Invasive pituitary adenomas and pituitary carcinomas, in Lloyd RV (ed): Surgical Pathology of the Pituitary Gland. Philadelphia, W.B. Saunders, Co., 1993, pp 121-136.
27. Pernicone P, Scheithauer B, Sebo T, Kovacs K, Horvath E, Young WF Jr, Ebersold MJ: Pituitary carcinoma: A clinicopathologic study of fifteen cases. J Neuropathol Exp Neurol 54:456, 1995 (abstr).
28. Scheithauer B, Kovacs K, Laws ER Jr, Randall RV: Pathology of invasive pituitary tumors with special reference to functional classification. J Neurosurg 65:733-744, 1986.
29. Selman WR, Laws ER Jr, Scheithauer BW, Carpenter SM: The occurrence of dural invasion in pituitary adenomas. J Neurosurg 64:402-407, 1986.
30. Shurbaji M, Kalfleisch J, Thurmond T: Immunohistochemical detection of p53 protein as a prognostic indicator in prostate cancer. Hum Pathol 26:106-109, 1995.
31. Silvestrini R, Benini E, Daidone MG, Veneroni S, Boracchi P, Cappelletti V, Di Fronzo G, Veronici U: p53 as an independent prognostic factor in lymph node-negative breast cancer patients. J Natl Cancer Inst 85:965-970, 1993.
32. Silvestrini R, Rao S, Benini E, Daidone MG, Pilotti S: Immunohistochemical detection of p53 in clinical breast cancers: A look at methodological approaches. J Natl Cancer Inst 87:1020, 1995 (letter).
33. Sumi J, Stefaneanu L, Kovacs K, Asa S, Rindi G: Immunohistochemical study of p53 protein in human and animal pituitary tumors. Endocr Pathol 4:95-99, 1993.
34. Taylor CR, Shan-Rong S, Chaiwun B, Young L, Imam SA, Cote RJ: Strategies for improving the immunohistochemical staining of various intranuclear prognostic markers in formalin-paraffin sections: Androgen receptor, estrogen receptor, progesterone receptor, p53 protein, proliferating cell nuclear antigen, and Ki-67 antigen revealed by antigen retrieval techniques. Hum Pathol 25:263-270, 1994.
35. Thapar K, Kovacs K, Muller P: Clinical-pathologic correlations of pituitary tumors. Baillieres Clin Endocrinol Metab 9:243-270, 1995.
36. Thapar K, Kovacs K, Scheithauer BW, Stefaneanu L, Horvath E, Pernicone PJ, Murray D, Laws EJ Jr: Proliferative activity and invasiveness among pituitary adenomas and carcinomas: An analysis using the MIB-1 antibody. Neurosurgery 38:99-107, 1996.
37. Thor A, Moore D, Edgerton S, Kawasaki ER, Reihsaus E, Lynch HT, Marcus JN, Schwartz L, Chen LC, Mayall BH, Smith H: Accumulation of p53 tumor suppressor gene protein: An independent prognostic marker of prognosis in breast cancers. J Natl Cancer Inst 84:845-855, 1992.
38. Wang D-Y, Xiang Y-Y, Tanaka M, Li X-R, Shen Q, Sugimura H, Kino I: High prevalence of p53 protein overexpression in patients with esophageal cancer in Linxian, China and its relationship to progression and prognosis. Cancer 74:3089-3096, 1994.